By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antiparkinson agents > Istradefylline > Istradefylline Dosage
Miscellaneous antiparkinson agents
https://themeditary.com/dosage-information/istradefylline-dosage-9402.html

Istradefylline Dosage

Drug Detail:Istradefylline (Istradefylline [ is-tra-def-i-lin ])

Drug Class: Miscellaneous antiparkinson agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Parkinson's Disease

Initial dose: 20 mg orally once a day

  • Dose may be increased based on individual need and tolerability
Maintenance dose: 20 to 40 mg orally once a day
Maximum dose: 40 mg/day

Use: As adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes.

Renal Dose Adjustments

CrCl 15 to 89 mL/min: No adjustment recommended
CrCl less than 15 mL/min: Data not available

Liver Dose Adjustments

Mild hepatic impairment (Child-Pugh A): No adjustment recommended
Moderate hepatic impairment (Child-Pugh B): Maximum dose: 20 mg orally once a day
Severe hepatic impairment (Child-Pugh C): Avoid use

Dose Adjustments

Concomitant Use with Strong CYP450 3A4 Inhibitors:

  • Maximum istradefyilline dose: 20 mg orally once a day

Concomitant Use with Strong CYP450 3A4 Inhibitors:
  • Avoid istradefyilline use

Tobacco Use:
  • For patients who smoke 20 or more cigarettes per day (or equivalent of another tobacco product): 40 mg orally once a day

Precautions

CONTRAINDICATIONS: None

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Take orally once a day with or without food

General:
  • This drug should be taken with levodopa/carbidopa.

Monitoring:
  • Monitor for increased dyskinesias
  • Monitor for hallucinations/psychotic behavior
  • Question patients on intense urges

Patient advice:
  • Patients should be instructed to read the US FDA-approved patient labeling (Patient Information).
  • Patients should understand that this drug may cause dyskinesia, exacerbate preexisting dyskinesia, cause intense urges, and/or cause hallucinations or psychotic behavior; if any of these behaviors occur, they should be instructed to report them to their healthcare provider.
  • Patients should understand that this drug may interact with other drugs including over-the-counter drugs, dietary supplements, and herbal products; they should be instructed to inform their health care provider of all medications they are taking, plan to take, or will stop taking.
  • Patients should understand that tobacco products may cause this drug to be less effective and a higher dose may be needed if they smoke 20 or more cigarettes a day.
  • Women of childbearing potential should be advised to use contraception during treatment.
Share this Article
Latest News
Medical News

Type 2 diabetes: Sugary drinks may significantly raise risk

May 30, 2025
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Ministrokes may result in 1 year of chronic fatigue
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by